Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Shanghai ChemPartner Closes Reverse Merger with Quantum
YiChang HEC Pharm Raises $400 Million from Blackstone Group
Buck Institute, Insilico and Juvenescence Form Napa to Develop Anti-Aging Drug
Loncar Launches China BioPharma ETF on NASDAQ Exchange
CrownBio Acquires Rights to Drug Development Models from Shanghai Model Organisms
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Device China 2018
September 8-9, 2018